Search results
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks via Yahoo News· 2 months agoUltragenyx (RARE) reports dismal first-quarter 2024 results, missing both earnings and revenue...
Ultragenyx (RARE) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo News· 8 months agoUltragenyx (RARE) reports weaker-than-expected third-quarter 2023 results, missing earnings and...
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo News· 9 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
Orchard Therapeutics PLC Sponsored ADR (ORTX) Surges 96.0%: Is This an Indication of Further Gains?
Zacks via Yahoo News· 9 months agoOrchard Therapeutics PLC Sponsored ADR (ORTX) was a big mover last session on higher-than-average...
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 6.9% Since Last Earnings Report?
Zacks via Yahoo News· 1 year agoA month has gone by since the last earnings report for Reata Pharmaceuticals, Inc. (RETA). Shares...
Reata (RETA) Q1 Earnings Miss, Stock Dips on Pipeline Updates
Zacks via Yahoo News· 1 year agoReata (RETA) incurs wider-than-expected loss in the first quarter. The company discontinues the...
Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View
Zacks via Yahoo News· 2 years agoAmgen AMGN reported third-quarter 2022 earnings of $4.70 per share, which beat the Zacks Consensus...
Ultragenyx's (RARE) Q3 Earnings Miss Estimates, Revenues Up Y/Y
Zacks via Yahoo News· 2 years agoUltragenyx Pharmaceutical Inc. RARE incurred a loss of $3.50 per share in third-quarter 2022, which...
Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M
Zacks via Yahoo News· 2 years agoUltragenyx (RARE) sells 30% of the royalty interest receivable on future North America sales of...